Moderna Therapeutics

Regional News • Europe
Switzerland: Country signs deal with Moderna for Coronavirus vaccine
Switzerland: Country signs deal with Moderna for Coronavirus vaccine
Credit: Photo: Mykenzie Johnson; Image Manipulation: Pendect

The Swiss government signed a deal with Moderna for early access to 4.5 million doses of a Coronavirus vaccine. It is expected that two doses will be needed for every person, therefore the Moderna deal could cover up to one quarter of the Swiss population. The country is in talks with several other vaccine companies.

Health
First COVID-19 vaccine tested

According to Associated Press the first COVID-19 vaccine was tested at the Kaiser Permanente research facility in Seattle, Washington. The vaccine was developed by the biotechnology company Moderna Therapeutics and contains a harmless part of the COVID-19 viral genome. The NHS-funded trial was fast-tracked, skipping animal experiments. According to the researchers, results may take many months.